US equities |
SPCX $171.09 ▲+0.00% NVDA $238.90 ▲+0.00% MU $1,063.96 ▲+0.00% AMD $631.75 ▲+0.00% SNDK $1,704.16 ▲+0.00% TSLA $378.73 ▲+0.00% SKHY $195.02 ▲+0.00% SDEV $3.94 ▲+0.00%
FinancialContent

IGM Biosciences, Inc. - Common Stock (NQ:IGMS)

1.270 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IGM Biosciences, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
News headline image
10 Health Care Stocks Whale Activity In Today's Session ↗
 
Via Benzinga
News headline image
IGM Biosciences to Present at Two Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023
Presentations highlight data from across all oncology pipeline programs 
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
Where IGM Biosciences Stands With Analysts ↗
 
Via Benzinga
News headline image
Earnings Preview For IGM Biosciences ↗
 
Via Benzinga
IGM Biosciences's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
Why Y-mAbs Therapeutics Shares Are Trading Higher By 50%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗
Gainers Y-mAbs Therapeutics, Inc (NASDAQ: YMAB) climbed 49.9% to $4.93 after the company posted a profit for the fourth quarter. 
Via Benzinga
News headline image
Ensysce Biosciences, AST SpaceMobile, IGM Biosciences And Other Big Stocks Moving Lower On Friday ↗
U.S. stocks traded higher, with the Dow Jones gaining more than 200 points on Friday. Here are some big stocks recording losses in today’s session. 
Via Benzinga
News headline image
IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences to Announce Fourth Quarter and Full Year 2022 Financial Results and Host Conference Call and Webcast on March 30, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
Roku Has 26% Of Cash With SVB Financial, Deposit Recovery Uncertain — 27 Other Companies With Ties To Collapsed Bank ↗
The collapse of SVB Financial Group (NASDAQ: SIVB) could have a ripple effect on the technology and biotech industries, the two largest sectors that had deposits and financial relationships with the... 
Via Benzinga
News headline image
IGM Biosciences to Present at the Guggenheim 2023 Oncology Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences Initiates First-in-Human Clinical Trial of IGM-7354 in Solid Tumors
– Targeted IL-15/IL-15R IgM antibody to be evaluated for safety and pharmacodynamic effects – 
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
TSMC, CommScope Holding And Other Big Stocks Moving Higher On Thursday ↗
U.S. stocks traded higher, with the Dow Jones gaining around 150 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
News headline image
Why KNOT Offshore Partners Shares Are Trading Lower By Around 38%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers BigBear.ai Holdings, Inc. (NYSE: BBAI) shares jumped 239% to $2.8715 after the company announced it has been awarded a multiple award $900 million Indefinite Delivery/Indefinite Quantity... 
Via Benzinga
News headline image
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences to Present at the 41st Annual J.P. Morgan Healthcare Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences Presents Data from T cell Engager Portfolio for Hematologic Malignancies at 2022 American Society of Hematology Annual Meeting
First Preclinical Data for IGM-2644 and IGM-2537 Featured in Poster Presentations 
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences to Present at the Bank of America Biotech SMID Cap Conference
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
Unity Software, Amazon, Doximity And Other Big Gainers From Friday ↗
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session. 
Via Benzinga
News headline image
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday ↗
Gainers Satixfy Communications Ltd. (NYSE: SATX) jumped 96.4% to settle at $51.70 on Thursday. 
Via Benzinga
News headline image
$10 Million Bet On Rain Therapeutics? Check Out These 4 Stocks Insiders Are Buying ↗
Although US stocks closed sharply higher on Thursday, there were a few notable insider trades. 
Via Benzinga
News headline image
Why Tattooed Chef Shares Dipped Around 15%; Here Are 95 Biggest Movers From Friday ↗
Gainers ShiftPixy, Inc. (NASDAQ: PIXY) shares surged 56.6% to settle at $19.10 on Friday. 
Via Benzinga
News headline image
Why Apyx Medical Shares Dipped Over 60%; Here Are 123 Biggest Movers From Yesterday ↗
Gainers 
Via Benzinga
News headline image
IGM Biosciences to Present at Three Upcoming Investor Conferences
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences Announces Third Quarter 2022 Financial Results and Provides Corporate Update
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
IGM Biosciences and ADC Therapeutics Announce Clinical Collaboration Agreement to Evaluate Imvotamab (IGM-2323) in Combination with ZYNLONTA® in Patients with Relapsed or Refractory B Cell Non-Hodgkin’s Lymphoma
From IGM Biosciences, Inc.
Via GlobeNewswire
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2022 ↗
Upgrades 
Via Benzinga
News headline image
Why F45 Training Shares Climbed 41%; Here Are 84 Biggest Movers From Friday ↗
Gainers FingerMotion, Inc. (NASDAQ: FNGR) gained 82.2% to close at $3.37. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >